Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Cancer hallmarks allow the complexity and heterogeneity of tumor biology to be better understood, leading to the discovery of various promising targets for cancer therapy. An amorphous iron oxide nanoparticle (NP)-based RNAi strategy is developed to co-target two cancer hallmarks. The NP technology can modulate the glycolysis pathway by silencing MCT4 to induce tumor cell acidosis, and concurrently exacerbate oxidative stress in tumor cells via the Fenton-like reaction. This strategy has the following features for systemic siRNA delivery: 1) siRNA encapsulation within NPs for improving systemic stability; 2) effective endosomal escape through osmotic pressure and/or endosomal membrane oxidation; 3) small size for enhancing tumor tissue penetration; and 4) triple functions (RNAi, Fenton-like reaction, and MRI) for combinatorial therapy and in vivo tracking.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898800 | PMC |
| http://dx.doi.org/10.1002/anie.201710144 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Deciphering pancreatobiliary intraductal oncocytic papillary neoplasms: integrative analysis of histomorphologic patterns, immunophenotypic markers, and emerging molecular biomarkers.
World J Surg Oncol
September 2025
Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No.1 Shuaifuyuan Dongcheng District, Beijing, 100730, China.
Purpose: We reviewed recent advancements in the characterization of intraductal oncocytic papillary neoplasm (IOPN) of the pancreas, with a specific focus on developments in immunohistochemical markers, molecular pathology, and pathogenic mechanisms over the past ten years (2015-2024). Through comprehensive analysis of current literature, we aimed to elucidate the evolving understanding of IOPN's biological behavior and diagnostic features, while identifying potential areas for future research in this distinctive pancreatic neoplasm.
Methods: English-language articles on IOPN were searched from Pubmed from the first report of IOPN of the pancreas in 2015 to 2024.
[Frailty in oncogeriatrics].
Inn Med (Heidelb)
September 2025
Comprehensive Cancer Center, Universitätsklinik Würzburg, Würzburg, Deutschland.
Frailty is a common geriatric syndrome in older patients with cancer. It affects prognosis and treatment tolerance in various ways. Frailty and cancer share several common risk factors, which are reflected in the hallmarks of aging.
View Article and Find Full Text PDFThe current report on drug development focuses on "The new dimension" of cancer hallmarks.
Gene
September 2025
Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 55281 Yogyakarta, Indonesia; Laboratory of Advanced Pharmaceutical Sciences. APSLC Building, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, 552
Cancer remains a significant global challenge, affecting millions, but progress has been made in understanding its development and advancement. The discovery of cancer drugs focuses on identifying "new dimension" hallmarks of cancer, such as phenotypic plasticity, senescence, polymorphic microbiota, and non-mutational epigenetic reprogramming. These elements are crucial in tumor development and treatment.
View Article and Find Full Text PDFThe multifaceted role of HJURP in cancer: Implications for tumorigenesis and therapeutic targeting.
Gene
September 2025
Amity Institute of Health Allied Sciences, Amity University, Noida, Uttar Pradesh, India. Electronic address:
Background: Holliday Junction Recognition Protein (HJURP) is essential for centromere integrity and chromosomal stability through its role in CENP-A deposition. Emerging studies suggest that HJURP also contributes to various aspects of cancer biology, including tumor initiation, progression, and metastasis.
Objective: To comprehensively review the molecular and clinical relevance of HJURP in cancer, with a focus on its role in genomic maintenance, cancer hallmarks, and its potential as a prognostic biomarker and therapeutic target.
Therapeutic Potential of CAPE in Targeting Hallmarks of Cancer in TPC-1 Thyroid Cancer Cells Through Modulation of Mitochondrial Membrane Potential.
J Biochem Mol Toxicol
September 2025
Department of Molecular Biology and Genetics, Institute of Natural and Applied Sciences, Van Yüzüncü Yıl University, Van, Türkiye.
The objective of this study was to examine the chemotherapeutic effect of CAPE, via the mitochondrial membrane potential (MMP, Δψm) pathway in TPC-1 human papillary thyroid cancer cells. The cytotoxic effect of CAPE was evaluated using MTT and crystal violet assays, while its apoptotic activity was measured using Bax, Bcl-2, Caspase-3,-8,-9 and Apaf-1 assays. Effects on mitochondria were performed by analyzing JC-1 fluorescent probe-MMP, ROMO1 and mitochondrial ATP-synthase.
View Article and Find Full Text PDF